2010-27330. Submission for OMB Review; Comment Request; Cancer Trials Support Unit (CTSU) Public Use Forms and Customer Satisfaction Surveys (NCI)
-
Start Preamble
SUMMARY:
Under the provisions of Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the National Cancer Institute (NCI), the National Institutes of Health (NIH), has submitted to the Office of Management and Budget (OMB) a request to review and approve the information collection listed below. This proposed information collection was previously published in the Federal Register on July 13, 2010 (75 FR 39950) and allowed 60-days for public comment. There have been no public comments. Additionally, the 30-day Federal Register was published on September 13, 2010. The purpose of this notice is to allow an additional 30 days for public comment to the revisions. The National Institutes of Health may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number.
Proposed Collection: Title: Cancer Trial Support Unit (CTSU). Type of Information Collection Request: Existing Collection in Use Without an OMB Number. Need and Use of Information Collection: CTSU collects annual surveys of customer satisfaction for clinical site staff using the CTSU Help Desk and the CTSU Web site. An ongoing user satisfaction survey is in place for the Oncology Patient Enrollment Network (OPEN). User satisfaction surveys are compiled as part of the project quality assurance activities and used to direct improvements to processes and technology. In addition, the CTSU collects standardized forms to process site regulatory information, changes to membership, patient enrollment data, and routing information for case report forms. This questionnaire adheres to The Public Health Service Act, Section 413 (42 U.S.C. 285a-2) authorizes CTEP to establish and support programs to facilitate the participation of qualified investigators on CTEP-supported studies, and to institute programs that minimize redundancy among grant and contract holders, thereby reducing overall cost of maintaining a robust treatment trials program. Based on a conversation with the Office of Management and Budget on October 17, 2010, the burden table has been revised to take into account future submissions of a generic data transmittal forms (see Attachment 1gg in the Table below). It was agreed that the generic forms will be finalized and submitted in the future as non-substantive change requests for OMB clearance as needed. Frequency of Response: The help desk and Web site survey are collected annually. The OPEN survey is ongoing. The form submissions vary depending on the purpose of the form and the activity of the local site. Affected Public: CTSU's target audience is staff members at clinical sites and CTEP-supported programs. Respondent and burden estimates are listed in the Table below. The annualized burden is estimated to be 34,802 hours and the annualized cost to respondents is estimated to be $946, 601. There are no Capital Costs, Operating Costs, and/or Maintenance Costs to report.
Attach No. Section/form or survey title Use metrics/ month— # respond Estimated time for site to complete (minutes) Estimated burden (minutes/ hours) Frequency of response Total annual usage/annual burden hours Regulatory/Roster 1a CTSU IRB/Regulatory Approval Transmittal Form 9,000 2 0.03 12.00 3,600 1b CTSU IRB Certification Form 8,500 10 0.17 12.00 17,000 1c CTSU Acknowledgement Form 500 5 0.08 12.00 500 1d Optional Form 1—Withdrawal from Protocol Participation Form 50 5 0.08 12.00 50 Roster Forms 1e CTSU Roster Update Form 50 2-4 0.07 12.00 40 1f CTSU Radiation Therapy Facilities Inventory Form 20 30 0.50 12.00 120 Drug shipment Start Printed Page 66768 1g CTSU IBCSG Drug Accountability Form 11 5-10 0.17 12.00 22 1h CTSU IBCSG Transfer of Investigational Agent Form 3 20 0.33 12.00 12 Data Management 1i Site Initiated Data Update Form (generic) 100 5-10 0.17 12.00 200 1j N0147 CTSU Data Transmittal Form 1000 5-10 0.17 12.00 2,000 1k Site Intimated Data Update Form (DUF), Protocol: NCCTG N0147* 75 5-10 0.17 12.00 150 1l TAILORX/PACCT 1 CTSU Data Transmittal Form 2100 5-10 0.17 12.00 4,200 1m Data Clarification Form 650 15-20 0.33 12.00 2,600 1n Unsolicited Data Modification Form (UDM), Protocol: TAILORx/PACCT1 75 5-10 0.17 12.00 150 1o Z4032 CTSU Data Transmittal Form 50 5-10 0.17 12.00 100 1p Z1031 CTSU Data Transmittal Form 50 5-10 0.17 12.00 100 1q Z1041 CTSU Data Transmittal Form 50 5-10 0.17 12.00 100 1r Z6051 CTSU Data Transmittal Form 75 5-10 0.17 12.00 150 1s RTOG 0834 CTSU Data Transmittal Form* 60 5-10 0.17 12.00 120 1t CTSU 7868 Data Transmittal Form 50 5-10 0.17 12.00 100 1u Site Initiated Data Update Form, protocol 7868 10 5-10 0.17 12.00 20 1v MC0845(8233) CTSU Data Transmittal* 50 5-10 0.17 12.00 100 1w 8121 CTSU Data Transmittal Form* 100 5-10 0.17 12.00 200 1x Site Initiated Data Update Form, Protocol 8121 10 5-10 0.17 12.00 20 1y USMCI 8214/Z6091: CTSU Data Transmittal *In Development 50 5-10 0.17 12.00 100 1z USMCI 8214/Z6091 Crossover Request/Checklist Transmittal Form 5 5-10 0.17 12.00 10 Patient Enrollment 1aa CTSU Patient Enrollment Transmittal Form 600 5-10 0.17 12.00 1,200 1bb CTSU P2C Enrollment Transmittal Form 30 5-10 0.17 12.00 60 1cc CTSU Transfer Form 40 5-10 0.17 12.00 80 Administrative 1dd CTSU System Account Request Form 50 15-20 0.33 12.00 200 1ee CTSU Request for Clinical Brochure 35 10 0.17 12.00 70 1ff CTSU Supply Request Form 130 5-10 0.17 12.00 260 1gg CTSU Generic Data Transmittal Form 500 5-10 0.17 12.00 1000.00 Surveys/Web Forms 2 CTSU Web Site Customer Satisfaction Survey 250 10-15 0.2500 1.00 63 3 CTSU Helpdesk Customer Satisfaction Survey 300 10-15 0.2500 1.00 75 4 CTSU OPEN Survey 120 10-15 0.2500 1.00 30 Annual Totals 21,770 34,802 Request for Comments: Written comments and/or suggestions from the public and affected agencies should address one or more of the following points: (1) Evaluate whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility; (2) Evaluate the accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) Enhance the quality, utility, and clarity of the information to be collected; and (4) Minimize the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology.
Direct Comments to OMB: Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the Attention: NIH Desk Officer, Office of Management and Budget, at OIRA_submission@omb.eop.gov or by fax to 202-395-6974. To request more information on the proposed project or to obtain a copy of the data collection plans and instruments, contact Michael Montello, Pharm. D., CTEP, 6130 Executive Blvd., Rockville, MD 20852, call non-toll-free number 301-435-9206 or e-mail your request, including your address to: montellom@mail.nih.gov. Start Printed Page 66769
Comments Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30 days of the date of this publication.
Start SignatureDated: October 21, 2010.
Vivian Horovitch-Kelley,
NCI Project Clearance Liaison, National Institutes of Health.
[FR Doc. 2010-27330 Filed 10-28-10; 8:45 am]
BILLING CODE 4140-01-P
Document Information
- Comments Received:
- 0 Comments
- Published:
- 10/29/2010
- Department:
- National Institutes of Health
- Entry Type:
- Notice
- Document Number:
- 2010-27330
- Dates:
- Comments regarding this information collection are best assured of having their full effect if received within 30 days of the date of this publication.
- Pages:
- 66767-66769 (3 pages)
- PDF File:
- 2010-27330.pdf
- Supporting Documents:
- » License Agreements; Start-Up Exclusive Evaluation Option: Activators of Human Pyruvate Kinase to Treat Cancer
- » Meetings: Eunice Kennedy Shriver National Institute of Child Health and Human Development
- » Meetings: National Institute of Nursing Research
- » Meetings: National Institute of Allergy and Infectious Diseases
- » Meetings: National Eye Institute
- » Meetings: Eunice Kennedy Shriver National Institute of Child Health and Human Development
- » Meetings: Center for Scientific Review
- » Meetings: Center for Scientific Review
- » Meetings: National Institute of Environmental Health Sciences
- » Meetings: National Human Genome Research Institute